Business
Ibogaine For Addiction: 5 Reasons Why It’s Safer To Do It In A Hospital
As it is a complex medical intervention, with physical and psychological effects, the use of ibogaine for detoxification requires the presence of qualified doctors and mental health professionals to provide treatment.
Ibogaine is a substance extracted from the root of the iboga, a shrub that grows in West Africa. For thousands of years, it has been used by indigenous cultures for healing rituals. Since the 1960s, a series of studies have been carried out, both in animals and in humans, which have shown its properties to reduce the withdrawal syndrome to opiates and other substances that cause addiction.
Current scientific evidence confirms that ibogaine has potentially useful effects to treat chemical dependency, which is why various clinics worldwide have begun to offer this type of therapy. However, it must be taken into account that it is a drug with a high level of toxicity and that its irresponsible intake carries risks for the patient that can even mean death. It is for this reason that it is essential, to guarantee your safety, that the provision of these treatments is carried out in environments equipped with an infrastructure and a team of suitable professionals, according to the standards of modern medicine.
Here are five reasons why ibogaine-based addiction treatments should be done in hospital settings.
- Need To Perform The Intervention In A Safe And Legal Environment, With The Necessary Medical Equipment And Infrastructure
- Need For Prior Medical And Psychological Examinations To Determine Contraindications
- The Hospital Environment Contributes To The Physical Preparation Prior To The Session
- Carrying Out The Session In A Hospital Environment Allows Adequate Monitoring By Health Professionals To Avoid Or Reduce The Side Effects of Ibogaine
- Need For Therapeutic Follow-up After The Session To Integrate The Treatment And Avoid Relapses
Need To Perform Intervention In A Safe, Legal Environment, With The Necessary Medical Equipment And Infrastructure
Ibogaine exerts its action directly on the Central Nervous System, causing physical and psychological effects on the body. Its high level of toxicity carries with it some dangers associated with the dose and the context in which it is ingested. It is for this reason that it is essential that the sessions are carried out in a pleasant environment and capable of guaranteeing patient support. This must have adequate infrastructure (spacious and clean facilities), as well as the necessary medical supplies (cardiac monitoring devices and defibrillators) so that the treatment is safe.
It is also of great importance that the center where the session is held adheres to the ethical codes and established medical protocols. Some providers often offer these therapies clandestinely and illegally in unregulated settings, which carries considerable risks. It should be considered that, internationally, the medicinal use of ibogaine is prohibited in several countries.
The therapies assisted by this substance to treat patients with addiction are legal, however, in some Latin American countries. In Mexico, for example, there are several private centers that legally offer this type of therapy, although state regulations in this country do not require that they be carried out in hospital settings. For its part, in Brazil, ibogaine is neither registered nor prohibited, its importation and use being legal since 2013 as long as the patient has a medical prescription. A decree of the state of Sao Paulo in 2016 requires that treatments based on the intake of ibogaine must be carried out under medical supervision and in hospital settings. These types of regulations are essential to ensure the safe and legal use of ibogaine.
Need For Prior Medical And Psychological Examinations To Determine Contraindications
It is highly probable, due to the high toxicity of ibogaine, that its intake may have unwanted effects on the functioning of the organism, mainly the Cardiac System. It is for this reason that it is usually contraindicated in patients with cardiovascular problems. Before carrying out the treatment, it is necessary for the patient to undergo a thorough medical examination to determine if it will be risky or not. Each case must be analyzed by a qualified doctor who determines if the patient meets the necessary physical conditions to start the session.

Ibogaine is also contraindicated in patients with psychiatric disorders such as schizophrenia, psychosis, bipolar disorder, or borderline personality disorder. Carrying out psychological or psychiatric examinations prior to the start of treatment is, therefore, of great importance. The mental health professional in charge of these check-ups must evaluate the presence of these disorders and their severity in order to establish whether the patient is able to resist treatment without complications.
It is from these studies that the professionals in charge will determine whether or not it is risky to carry out the treatment and, if they decide that it is pertinent to do so, they will take the necessary precautions to reduce the possible risks during the session.
The Hospital Environment Contributes To The Physical Preparation Prior To The Session
Ibogaine is a powerful drug whose effects can cause a physically intense experience for the patient. It is for this reason that, the better the physical condition of the latter, the more intervention will be safer and more efficient. Generally, doctors recommend good hydration, a careful diet, based on healthy foods, and the intake of vitamin and mineral supplements. Likewise, it is recommended to stop consuming water and fast a few hours before the session, since it is difficult to have to go to the bathroom during the session due to the ataxia induced by ibogaine intake.
On the other hand, it is essential that weeks before and during the administration of the treatment, the patient avoids the consumption of any type of psychoactive. Indeed, the interaction of certain drugs with ibogaine could increase cardiac risks, even causing death. It is for this reason that many centers tend to carry out a guided detoxification process sometime before ingestion, thus increasing the safety of the session considerably.
Carrying Out The Session In A Hospital Environment Allows Adequate Monitoring By Health Professionals To Avoid Or Reduce The Side Effects of Ibogaine
Therapeutic interventions based on the intake of ibogaine are often controversial due to the risks they entail. Among the most frequent side effects are the presence of dizziness, nausea, vomiting, motor coordination difficulties, and tachyarrhythmias.
It can be inferred, therefore, that it is necessary for the sessions to be monitored by highly qualified health professionals who carry out an adequate follow-up to avoid or reduce possible unwanted damage induced by ibogaine. It is important that, during the sessions, the instructions of the doctor in charge are followed, who must adequately inform the patient about the possible adverse effects and dispel their doubts in the event that there are any. The presence of nurses or caregivers is usually recommended after the end of the experience. Carrying out the intake in a hospital environment will ensure the presence of health professionals for proper follow-up.

As it is a complex medical intervention, with physical and psychological effects, the use of ibogaine for detoxification requires, in addition to the presence of qualified doctors to provide the treatment, the support of mental health professionals, such as psychiatrists, psychologists, or psychotherapists. This is of great importance because not all patients manage to deal with the introspective experience produced by ibogaine, and may suffer episodes of anxiety and paranoia. Personalized follow-up by these professionals will reduce the side effects of ibogaine on the patient’s psyche and improve the intake experience.
Need For Therapeutic Follow-up After Session To Integrate Treatment And Avoid Relapses
The intake of ibogaine is an instance of a larger therapeutic process. It is for this reason that it is important to maintain the necessary aftercare to carry out the treatment successfully. The design of a care plan after the session constitutes an essential part of the treatment and must be monitored by the team of professionals in charge of it. Generally, it is recommended that the centers in which the treatment is applied offer a plan of continued care after the session or, at least, articulate and collaborate with other therapeutic centers in charge of offering this care.
Psychological support is a key factor in guaranteeing the success of treatment. During the session and the days that follow, patients usually undergo a process of considerable psychological changes and personal redefinition, which is why it is of great importance that they have the support of mental health professionals to gradually return to their daily lives.
Likewise, it is necessary that the post-session follow-up by the medical team focuses on avoiding relapses. It should be considered that once ingested, the tolerance to the substance that generated addiction in the patient tends to be much lower than before. This means that the usual doses that he was used to could have more severe effects on the body and even cause an overdose. Having a relapse does not mean that the therapeutic process itself has been useless; in some cases, professionals evaluate, the application of a second dose to improve the recovery process.
Business
Jio’s 1,600-Satellite LEO Constellation Gets Technical Green Light
Reliance Jio has crossed a significant milestone in its space connectivity ambitions after its proposal to deploy a Low Earth Orbit (LEO) satellite constellation of around 1,600 satellites received a positive technical assessment from the Indian National Space Promotion and Authorisation Centre (IN-SPACe).
The evaluation, conducted jointly by IN-SPACe, the Indian Space Research Organisation (ISRO), and the Wireless Planning and Coordination (WPC) wing of the Department of Telecommunications, reportedly concluded that Jio’s proposed system meets the required technical standards and is comparable to leading global satellite broadband networks.
India’s Indigenous LEO Satellite Vision
Under the proposal, Reliance Jio plans to deploy between 1,600 and 1,650 satellites in Low Earth Orbit at an altitude of around 650 kilometres.
The planned constellation is expected to provide high-speed satellite connectivity across India, with approximately 32 satellites visible from any location at a given time. The company aims to roll out the network within the next two to three years, subject to regulatory approvals.
According to industry estimates, the satellite system could deliver 4.5 to 5 terabits per second (Tbps) of total data capacity, making it one of the largest satellite broadband projects proposed in India.
The project is expected to require an investment of $10–15 billion (approximately ₹95,000 crore to ₹1.42 lakh crore), reflecting the scale of infrastructure needed for satellite manufacturing, launches, ground stations, and user terminals.
Regulatory Process Moves Forward
Following the successful technical review, the proposal is expected to move into the next phase of regulatory approvals.
The government may now assist Jio in securing orbital slots, coordinating spectrum usage, and filing applications with the International Telecommunication Union (ITU), the global body responsible for managing satellite orbit and frequency allocations.
Obtaining orbital rights remains a critical step, as Low Earth Orbit has become increasingly competitive due to the growing number of satellite broadband projects being planned worldwide.
Officials also indicated that the proposed satellite architecture has been designed to coexist with future Indian LEO constellations, allowing multiple domestic operators to share orbital resources efficiently.
Broadband, Mobile Connectivity, and Strategic Applications
Jio plans to use the satellite network to provide a range of communication services, including satellite broadband, mobile backhaul, enterprise connectivity, and direct-to-device (D2D) satellite communication, particularly in remote and underserved regions where conventional telecom infrastructure is limited.
The company also intends to establish 20 to 22 ground stations across India to support network operations.
Apart from commercial telecommunications, officials have highlighted the project’s potential strategic importance. A domestically developed satellite constellation could strengthen India’s communication infrastructure, reduce dependence on foreign satellite operators, and support national security requirements.
Reports suggest preliminary discussions are underway regarding the possibility of integrating defence-related payloads into some satellites, enabling both civilian and strategic use.
Major Step for India’s Space and Telecom Sectors
Industry analysts view the technical clearance as an important milestone in India’s expanding private space ecosystem. If Jio secures the remaining regulatory approvals and international orbital clearances, the project could become the country’s first large-scale indigenous LEO satellite broadband network.
The initiative also aligns with India’s broader efforts to expand digital connectivity while strengthening its presence in the global satellite communications market.
Business
Alleged Crores Pharma Scam Mastermind Arrested from Surat
After evading law enforcement for nearly 13 years, an accused linked to a large-scale pharmaceutical fraud case has been arrested by Delhi Police from Surat, Gujarat. The suspect is alleged to have orchestrated a series of financial scams involving fake identities, forged documents, and dishonoured cheques used to procure high-value pharmaceutical raw materials.
Authorities say the accused, identified as Himmat Singh Lodha, is believed to have defrauded multiple pharmaceutical companies in Delhi of goods worth approximately ₹98 lakh before disappearing and remaining underground for years.
Fake Business Deals and Dishonoured Cheques Used in Fraud
Investigators claim the accused posed as a legitimate pharmaceutical trader and placed bulk orders for expensive drug ingredients, offering post-dated cheques as payment security.
In one documented case from 2013, he allegedly obtained around 550 kilograms of Gliclazide, a diabetes-related pharmaceutical ingredient, valued at over ₹26 lakh. When suppliers attempted to encash the cheques, they were reportedly returned with the remark “account closed.”
Following the transaction, the accused allegedly vacated his office and rented residence and disappeared without settling payments. He was later declared a proclaimed offender in 2016 after repeatedly failing to appear before court proceedings. Authorities had also issued a reward for information leading to his arrest.
Multiple Identities and Repeated Fraud Pattern
Police investigations further link the accused to another cheating case dating back to 2012, where he allegedly used a fake identity, “Kailash Jain,” to obtain a large consignment of Ambroxol HCL, a pharmaceutical compound used in cough medications. The value of that consignment was estimated at around ₹72 lakh.
Officials believe the accused followed a consistent modus operandi—posing as a credible businessman, securing high-value goods on deferred payment terms, and then disappearing after delivery while shutting down business operations.
Investigators suspect that forged business records, fake company credentials, and fabricated financial histories were used to build trust with suppliers and gain access to expensive raw materials.
Multi-State Surveillance Leads to Arrest in Surat
A special Crime Branch team tracked the accused through coordinated surveillance efforts across multiple cities, including Mumbai, Ahmedabad, and Surat. After nearly a month of technical monitoring and intelligence gathering, officials located and arrested him from a residential area in Surat.
Authorities also revealed that the accused had been involved in property-related activities while staying under the radar to avoid detection.
Growing Threat of Corporate Identity Fraud
The case highlights a rising trend of organised financial fraud targeting industries that rely heavily on trust-based transactions and deferred payments. Experts note that criminals increasingly exploit gaps in corporate verification systems by using fake GST registrations, temporary offices, and forged documentation to appear legitimate.
Cybercrime and financial fraud specialists warn that such schemes are becoming more complex with the widespread availability of digital business tools, making it easier to create convincing but fraudulent corporate identities.
Experts Urge Stronger Due Diligence in High-Value Transactions
Experts, including former IPS officer and cybercrime specialist Prof. Triveni Singh, emphasize the need for stricter verification procedures in commercial dealings. He noted that relying solely on paperwork or digital business profiles can expose companies to significant financial risk.
Authorities and industry experts recommend physical verification of business operations, bank account validation, and detailed background checks before engaging in high-value or deferred-payment transactions—particularly in sectors like pharmaceuticals, where single consignments can involve transactions worth crores.
Business
EU Pressure Builds on Google as Regulators Face Calls for Massive Fine Over Search Practices
A growing coalition of European industry groups is intensifying pressure on regulators to take decisive action against Google over allegations of unfair search practices that could reshape competition rules across the region’s digital economy.
Investigation Under Digital Markets Act Gains Momentum
The case is being examined by the European Commission under the European Union’s landmark Digital Markets Act (DMA), introduced to curb the dominance of major technology platforms and ensure fair competition.
Launched in March 2024, the investigation focuses on whether Google has been prioritising its own services in search results, potentially disadvantaging rival businesses that rely on online visibility to reach customers.
Industry Groups Demand Swift Action
Several prominent European organizations have jointly urged regulators to conclude the probe without further delay. They argue that prolonged investigations allow alleged anti-competitive practices to continue, putting European companies—especially startups—at a disadvantage.
Signatories include the European Publishers Council, the European Magazine Media Association, the European Tech Alliance, and EU Travel Tech.
In a joint statement, these groups warned that delays in enforcement are affecting innovation, profitability, and growth prospects for regional businesses competing in digital markets.
Google Denies Allegations
Google has rejected claims of bias, stating that its search algorithms are designed to deliver the most relevant and useful results to users. The company has also proposed adjustments to address regulatory concerns.
However, critics argue that these changes are insufficient and fail to address the core issue of market dominance.
Potential Billion-Euro Penalties
If found in violation of the DMA, Google could face significant financial penalties. Under EU rules, fines can reach a substantial percentage of a company’s global turnover, potentially amounting to billions of euros.
Regulators may also impose corrective measures requiring changes to business practices, which could have long-term implications for how digital platforms operate in Europe.
Wider Implications for Big Tech
The case highlights ongoing tensions between European regulators and major U.S. technology firms. In recent years, the EU has taken a more aggressive stance in enforcing competition laws, aiming to create a level playing field for local businesses.
A final ruling against Google could set a major precedent, influencing future enforcement actions and shaping the regulatory landscape for global tech companies operating within Europe.
As scrutiny intensifies, the outcome of the investigation is expected to play a critical role in defining the future of digital competition across the European Union.
-
Business3 years agoPot Odor Does Not Justify Probable Cause for Vehicle Searches, Minnesota Court Affirms
-
Business3 years agoNew Mexico cannabis operator fined, loses license for alleged BioTrack fraud
-
Business3 years agoAlabama to make another attempt Dec. 1 to award medical cannabis licenses
-
Business3 years agoWashington State Pays Out $9.4 Million in Refunds Relating to Drug Convictions
-
Business3 years agoMarijuana companies suing US attorney general in federal prohibition challenge
-
Business3 years agoLegal Marijuana Handed A Nothing Burger From NY State
-
Business3 years agoCan Cannabis Help Seasonal Depression
-
Blogs3 years agoCannabis Art Is Flourishing On Etsy
